In BD-treated cells, inflammatory responses, Wnt/β-catenin signaling, interleukin 6/Janus kinases/signal transducer and activator of transcription proteins 3 (IL-6/JAK/STAT3) signaling, and INF-γ responses were enriched after 72 h (Figure 3F). The gene discussed is STAT3; the disease is Behcet disease.